Pleckstrin homology domain (PH domain)

The Pleckstrin homology (PH) domain is a highly conserved structural module of approximately 120 amino acids found in over 250 human proteins, making it the 11th most common domain in the human proteome [1, 5, 6]. Its primary biological function is to facilitate the recruitment of proteins to the cell membrane by specifically binding to phosphoinositides, such as phosphatidylinositol (3,4,5)-trisphosphate (PIP3) and phosphatidylinositol (4,5)-bisphosphate (PIP2) [1, 11]. This membrane localization is a critical regulatory step for the activation of key signaling enzymes, most notably the serine/threonine kinase Akt and Bruton's tyrosine kinase (Btk), which govern cell survival, proliferation, and immune responses [5, 7, 12]. In many diseases, particularly cancer, the hyperactivation of the PI3K pathway leads to excessive PIP3 production and constitutive PH-domain-mediated membrane recruitment of oncogenic proteins [6, 12]. Consequently, the PH domain has become a significant therapeutic target for small molecule inhibitors designed to disrupt these lipid-protein interactions [2, 14]. While drugs like perifosine and triciribine have entered clinical trials, the high structural similarity among the hundreds of human PH domains presents a major challenge for achieving high selectivity and avoiding off-target toxicities [1, 6].

Other names

PH domainPleckstrin-like domainPHIP

Small molecule inhibitors bind to the PH domain to competitively block its interaction with phosphoinositides (such as PIP3), thereby preventing the translocation of the host protein to the plasma membrane and inhibiting its subsequent activation and downstream signaling [2, 6, 12].